MREO
Price
$0.64
Change
-$0.03 (-4.48%)
Updated
Jan 16 closing price
Capitalization
101.84M
73 days until earnings call
Intraday BUY SELL Signals
TRDA
Price
$11.00
Change
+$0.18 (+1.66%)
Updated
Jan 16 closing price
Capitalization
420.41M
59 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MREO vs TRDA

Header iconMREO vs TRDA Comparison
Open Charts MREO vs TRDABanner chart's image
Mereo BioPharma Group
Price$0.64
Change-$0.03 (-4.48%)
Volume$14.34M
Capitalization101.84M
Entrada Therapeutics
Price$11.00
Change+$0.18 (+1.66%)
Volume$299.09K
Capitalization420.41M
MREO vs TRDA Comparison Chart in %
MREO
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MREO vs. TRDA commentary
Jan 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MREO is a Hold and TRDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 19, 2026
Stock price -- (MREO: $0.64 vs. TRDA: $11.00)
Brand notoriety: MREO and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MREO: 80% vs. TRDA: 129%
Market capitalization -- MREO: $101.84M vs. TRDA: $420.41M
MREO [@Biotechnology] is valued at $101.84M. TRDA’s [@Biotechnology] market capitalization is $420.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MREO’s FA Score shows that 1 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • MREO’s FA Score: 1 green, 4 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both MREO and TRDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MREO’s TA Score shows that 6 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • MREO’s TA Score: 6 bullish, 4 bearish.
  • TRDA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MREO is a better buy in the short-term than TRDA.

Price Growth

MREO (@Biotechnology) experienced а +29.45% price change this week, while TRDA (@Biotechnology) price change was +9.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

MREO is expected to report earnings on Apr 01, 2026.

TRDA is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($420M) has a higher market cap than MREO($102M). MREO YTD gains are higher at: 53.588 vs. TRDA (7.004). MREO has higher annual earnings (EBITDA): -40.14M vs. TRDA (-117.36M). TRDA has more cash in the bank: 327M vs. MREO (48.7M). MREO has less debt than TRDA: MREO (397K) vs TRDA (52.4M). TRDA has higher revenues than MREO: TRDA (61.5M) vs MREO (500K).
MREOTRDAMREO / TRDA
Capitalization102M420M24%
EBITDA-40.14M-117.36M34%
Gain YTD53.5887.004765%
P/E RatioN/A10.26-
Revenue500K61.5M1%
Total Cash48.7M327M15%
Total Debt397K52.4M1%
FUNDAMENTALS RATINGS
MREO: Fundamental Ratings
MREO
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MREOTRDA
RSI
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MREO
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTIEX15.650.03
+0.19%
Fidelity Total International Equity
CBEAX10.68N/A
N/A
Allspring Large Cap Value CL A
FIUSX34.25-0.05
-0.15%
Nomura Opportunity A
WVMRX12.42-0.03
-0.24%
William Blair Mid Cap Value R6
JNGLX82.05-0.39
-0.47%
Janus Henderson Global Life Sciences D

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been closely correlated with RARE. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if MREO jumps, then RARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
-4.55%
RARE - MREO
84%
Closely correlated
-4.30%
TRDA - MREO
41%
Loosely correlated
+1.66%
XNCR - MREO
39%
Loosely correlated
-3.18%
SYRE - MREO
39%
Loosely correlated
+0.45%
NRIX - MREO
38%
Loosely correlated
+1.86%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with NRIX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+1.66%
NRIX - TRDA
52%
Loosely correlated
+1.86%
VYGR - TRDA
47%
Loosely correlated
-1.57%
CRNX - TRDA
46%
Loosely correlated
-0.78%
XNCR - TRDA
46%
Loosely correlated
-3.18%
VIR - TRDA
45%
Loosely correlated
-2.26%
More